Cite
HARVARD Citation
TAO, Y. et al. (2023). Extended follow-up of a phase 2 trial of xevinapant plus chemoradiotherapy in high-risk locally advanced squamous cell carcinoma of the head and neck: a randomised clinical trial. European journal of cancer. pp. 24-37. [Online].